Chemoinformaics analysis of CISSOGENIN
Molecular Weight | 366.498 | nRot | 1 |
Heavy Atom Molecular Weight | 332.226 | nRig | 20 |
Exact Molecular Weight | 366.241 | nRing | 4 |
Solubility: LogS | -3.083 | nHRing | 0 |
Solubility: LogP | 1.313 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 21 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 61.751 |
nHD | 5 | BPOL | 34.109 |
QED | 0.451 |
Synth | 4.947 |
Natural Product Likeliness | 3.172 |
NR-PPAR-gamma | 0.074 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.022 |
HIA | 0.735 |
CACO-2 | -5.066 |
MDCK | 0.000504786 |
BBB | 0.798 |
PPB | 0.391877 |
VDSS | 1.083 |
FU | 0.347423 |
CYP1A2-inh | 0.008 |
CYP1A2-sub | 0.374 |
CYP2c19-inh | 0.005 |
CYP2c19-sub | 0.762 |
CYP2c9-inh | 0.007 |
CYP2c9-sub | 0.505 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.219 |
CYP3a4-inh | 0.017 |
CYP3a4-sub | 0.132 |
CL | 7.661 |
T12 | 0.128 |
hERG | 0.013 |
Ames | 0.047 |
ROA | 0.815 |
SkinSen | 0.018 |
Carcinogencity | 0.233 |
EI | 0.006 |
Respiratory | 0.318 |
NR-Aromatase | 0.32 |
Antiviral | Yes |
Prediction | 0.560019 |